Characterization & Treatment of Chronic Pain After Moderate to Severe TBI
1 other identifier
observational
3,805
1 country
13
Brief Summary
This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
Typical duration for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 13, 2018
CompletedStudy Start
First participant enrolled
May 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFebruary 8, 2023
February 1, 2023
3.4 years
November 8, 2018
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Brief Pain Inventory (BPI)
The BPI will be used to determine pain intensity as well as interference related to pain. Intensity of pain is rated by participant on a scale of 0 (no pain) to 10 (pain as bad as you can imagine) when the pain is at it's "worst," "least," "average," and "right now." Pain interference is assessed with seven items using a numeric rating scale ranging from 0 (no interference) to 10 (complete interference). Participants are asked to rate how much pain has interfered with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life
Each participant will complete assessment one time during 4 years of data collection
painDetect Questionnaire
This self report survey consists of seven questions about location and quality of neuropathic pain. Scores range from 0-38 with scores above 18 indicating neuropathic pain and higher scores indicating more severity of pain.
Each participant will complete assessment one time during 4 years of data collection
Secondary Outcomes (3)
Post-Traumatic Stress Disorder Checklist-5 (PCL-5)
Each participant will complete assessment one time during 4 years of data collection
Pain Self Efficacy Questionnaire-2 (PSEQ-2)
Each participant will complete assessment one time during 4 years of data collection
Coping Strategies Questionnaire (CSQ)
Each participant will complete assessment one time during 4 years of data collection
Eligibility Criteria
All participants have sustained a moderate to severe TBI and are now being followed at the collaborating centers as part of the TBIMS NDB which is a study collecting observational data after TBI.
You may qualify if:
- Participants must be enrolled in the TBI Model Systems National Database (TBNIMS NDB) at one of the collaborating sites and thus will meet the TBIMS NDB criteria which are: (1) medical documentation of TBI caused by external mechanical force with either loss of consciousness exceeding 30 minutes, post-traumatic amnesia lasting more than 24 hours, Glasgow Coma Scale score in ER of less than 13, or trauma related intracranial abnormality or neuroimaging abnormalities; (2) admitted to the TBI inpatient rehab program at study sites; and (3) minimum age of 16 \[18 for VA site\]
You may not qualify if:
- Participants unable to participate in the surveys themselves will not be included (i.e. no proxy surveys).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Craig Hospitallead
- University of Washingtoncollaborator
- James A. Haley Veterans Administration Hospitalcollaborator
- Rehabilitation Hospital of Indianacollaborator
- Spaulding Rehabilitation Hospitalcollaborator
- Wayne State Universitycollaborator
- Mayo Cliniccollaborator
- Baylor Institute for Rehabilitationcollaborator
- Virginia Commonwealth Universitycollaborator
- NYU Langone Healthcollaborator
- University of Alabama at Birminghamcollaborator
- Moss Rehabilitation Research Institutecollaborator
- TIRR Memorial Hermanncollaborator
Study Sites (13)
University of Alabama
Birmingham, Alabama, 35294, United States
Craig Hospital
Englewood, Colorado, 80113, United States
Tampa VA
Tampa, Florida, 33612, United States
Indiana University
Indianapolis, Indiana, 46202, United States
Spaulding Rehabilitation Institute
Charlestown, Massachusetts, 02129, United States
Wayne State University
Detroit, Michigan, 78202, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
New York University School of Medicine
New York, New York, 10016, United States
MOSS Rehabilitation Research Institute
Elkins Park, Pennsylvania, 19027, United States
Baylor Research Institute
Dallas, Texas, 75204, United States
TIRR Memorial Hermann
Houston, Texas, 77030, United States
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Principal Investigator
Study Record Dates
First Submitted
November 8, 2018
First Posted
November 13, 2018
Study Start
May 20, 2019
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
February 8, 2023
Record last verified: 2023-02